Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
出版年份 2015 全文链接
标题
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
作者
关键词
Neuroendocrine tumor, Chromogranin, <sup>68</sup>Ga-PET, Gene transcripts, NETest, PRRT
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 43, Issue 5, Pages 839-851
出版商
Springer Nature
发表日期
2015-11-23
DOI
10.1007/s00259-015-3250-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies
- (2016) Irvin M. Modlin et al. SURGERY
- Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status
- (2015) Mark Kidd et al. ENDOCRINE-RELATED CANCER
- Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine
- (2015) Amir Sabet et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status
- (2015) L. Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC
- (2015) Stefano Severi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy
- (2015) Jarosław B. Ćwikła et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Consensus on biomarkers for neuroendocrine tumour disease
- (2015) Kjell Oberg et al. LANCET ONCOLOGY
- Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways
- (2015) Alessandro Valli et al. Oncotarget
- Defective pantothenate metabolism and neurodegeneration
- (2014) Susan J. Hayflick BIOCHEMICAL SOCIETY TRANSACTIONS
- Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges
- (2014) J. P. Castaño et al. CANCER AND METASTASIS REVIEWS
- Unraveling Tumor Grading and Genomic Landscape in Lung Neuroendocrine Tumors
- (2014) Giuseppe Pelosi et al. ENDOCRINE PATHOLOGY
- The 2010 WHO Classification of Digestive Neuroendocrine Neoplasms: a Critical Appraisal four years after Its Introduction
- (2014) G. Rindi et al. ENDOCRINE PATHOLOGY
- A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection
- (2014) Irvin M Modlin et al. ENDOCRINE-RELATED CANCER
- 177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study
- (2014) Giovanni Paganelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2014) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors
- (2014) C. Kratochwil et al. MOLECULAR IMAGING AND BIOLOGY
- Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
- (2013) Su-Chen Li et al. MODERN PATHOLOGY
- Treatment with the Radiolabelled Somatostatin Analog177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
- (2013) Maddalena Sansovini et al. NEUROENDOCRINOLOGY
- Early prediction of tumour response to PRRT
- (2013) S. Ezziddin et al. NUKLEARMEDIZIN-NUCLEAR MEDICINE
- Pattern and Clinical Predictors of Lymph Node Involvement in Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PanNETs)
- (2013) Stefano Partelli et al. JAMA Surgery
- Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors
- (2012) K Oberg Clinics
- Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
- (2012) Mohid S. Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Monitoring of Gastroenteropancreatic Neuroendocrine Tumors: The Challenges Ahead
- (2012) Anders Sundin et al. NEUROENDOCRINOLOGY
- THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
- (2012) Richard P. Baum et al. Theranostics
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Decreased expression of genes involved in oxidative phosphorylation in human pancreatic islets from patients with type 2 diabetes
- (2011) Anders H Olsson et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Biomarkers and Molecular Imaging in Gastroenteropancreatic Neuroendocrine Tumors
- (2011) D. Lindholm et al. HORMONE AND METABOLIC RESEARCH
- Ornithine Decarboxylase AntizymeOaz3Modulates Protein Phosphatase Activity
- (2011) Yibing Ruan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Response and Long-Term Control of Bone Metastases After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2011) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- Identification of a Novel Raf-1 Pathway Activator that Inhibits Gastrointestinal Carcinoid Cell Growth
- (2010) M. R. Cook et al. MOLECULAR CANCER THERAPEUTICS
- A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor (‘Carcinoid’) Survival
- (2010) Irvin M. Modlin et al. NEUROENDOCRINOLOGY
- Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
- (2010) Dik J. Kwekkeboom et al. SEMINARS IN NUCLEAR MEDICINE
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- (2009) Dik J Kwekkeboom et al. ENDOCRINE-RELATED CANCER
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
- (2009) Dermot O’Toole et al. NEUROENDOCRINOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
- (2008) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now